Compound	Maslinic acid
NPACT-Id	NPACT00758
IUPAC	(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
Synonyms	Crategolic acid;Crataegolic acid
PubChem Id	73659
Class	Terpenoids
In-vitro anticancer activity	3 cancer cell lines
In-Vivo anticancer activity	No
Targets	BAX \| BCL2 \| BID \| CASP3 \| CASP7 \| CASP8 \| CASP9 \| CYCS \| MAPK8 \| TP53 \| All \|
Properties	Physical Elemental Topological
InChi Key	MDZKJHQSJHYOHJ-LLICELPBSA-N
InChi	1S/C30H48O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20+,21-,22+,23-,27-,28+,29+,30-/m0/s1
SMILES	O[C@@H]1C([C@H]2[C@@]([C@@H]3[C@]([C@]4(C(=CC3)[C@H]3[C@@](CC4)(CCC(C3)(C)C)C(=O)O)C)(CC2)C)(C[C@H]1O)C)(C)C
SMART	[H]OC(=O)[C@]12C([H])([H])C([H])([H])[C@](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[C@@]1([H])C1=C([H])C([H])([H])[C@]3([H])[C@@]4(C([H])([H])[H])C([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@](C([H])([H])[H])(C([H])([H])[H])[C@]4([H])C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@]1(C([H])([H])[H])C([H])([H])C2([H])[H]
CAS No.	4373-41-5
Structure Download
Cross Refrence in other databases
	Super Natural	-
	CTD	C412811
	HIT	-
	NCI-60 GI₅₀ data	-
Suppliers	AAA Chemistry, ABBLIS Chemicals, ABI Chem, Kingston Chemistry, Therapeutic Targets Database,
Drug-Likeliness Filters	Lipinski's rule of five	No
	Ghose filter	No
	Veber filter	Yes
	Muegge Filter	No
Similarity Search	Human metabolite database	FDA approved drugs

NPACT

Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase

Help

FAQs

Statistics

Tool

Contact